Compare JBL & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JBL | HLN |
|---|---|---|
| Founded | 1966 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | 24524 |
| Industry | Electrical Products | Package Goods/Cosmetics |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.2B | 41.1B |
| IPO Year | 1998 | N/A |
| Metric | JBL | HLN |
|---|---|---|
| Price | $352.36 | $9.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 1 |
| Target Price | ★ $272.33 | N/A |
| AVG Volume (30 Days) | 1.0M | ★ 7.9M |
| Earning Date | 06-16-2026 | 02-26-2026 |
| Dividend Yield | 0.10% | ★ 1.94% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.43 | N/A |
| Revenue | ★ $25,282,320,000.00 | N/A |
| Revenue This Year | $15.81 | $6.55 |
| Revenue Next Year | $9.76 | $4.42 |
| P/E Ratio | $105.65 | ★ $49.05 |
| Revenue Growth | ★ 14.42 | N/A |
| 52 Week Low | $175.08 | $8.65 |
| 52 Week High | $384.70 | $11.28 |
| Indicator | JBL | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 49.81 | 48.40 |
| Support Level | $323.67 | $8.99 |
| Resistance Level | $378.54 | $9.44 |
| Average True Range (ATR) | 15.35 | 0.12 |
| MACD | -2.82 | 0.02 |
| Stochastic Oscillator | 27.67 | 60.54 |
Jabil Inc. is a U.S based company providing engineering, manufacturing, and supply chain solutions. It provides comprehensive electronics design, production, and product management services to companies in various industries and end markets. It operates through three segments: Regulated Industries, serving automotive, healthcare, and renewables; Intelligent Infrastructure, focused on AI, cloud, data centers, and communications, driving the majority of revenue; and Connected Living and Digital Commerce, specializing in digitalization and automation, such as robotics and warehouse automation. The company operates in the U.S., Mexico, China, Malaysia, Singapore, and several other markets.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.